Program
Workshops Thursday 23rd February 2017 |
|||||
|---|---|---|---|---|---|
| 8:30 |
Registration Opens |
||||
|
9:00 |
Inaugural Varian Users’ Workshop 0900 – 0920 Welcome 0920 – 1010 Keynote Presentation: Dr Bradley Prestidge 1010 – 1025 Morning Tea 1025 – 1045 Dr Bradley Prestidge 1045 – 1145 Workshop 1145 Conclusion |
||||
|
11:45 – 13:00 |
Lunch – Own arrangement |
||||
|
13:00 |
5th Oncentra Brachy User Group Meeting 1300 – 1310 Welcome and Introduction to Elekta 1310 – 1330 Treatment verification in brachytherapy – Should this be Standard of Care? 1330 – 1400 Elekta’s Vision on Treatment Verification in Brachytherapy 1400 – 1415 Update on TG 186 Model Based Dose Calculation Algorithms 1415 – 1430 Real time ultrasound-based high dose rate prostate brachytherapy: implementation and experience at St George Hospital 1430 – 1445 Afternoon tea 1445 – 1500 Esteya Electronic Brachytherapy for Skin Cancer 1500 – 1520 Radiobiology refresher: why is it important in brachytherapy? 1520 – 1540 Elekta’s Radiobiological App Introducing Venezia™ 1540 – 1600 “Can we move from 2D to 3D ultrasound based gynaecological brachytherapy?” A preliminary look at what is possible and what is needed. 1600 – 1615 Looking Back at Brachytherapy in Australia Closing Remarks |
||||
|
16:30 |
Day 1 concludes |
||||
|
17:30 – 19:30 |
Welcome Reception – SkyBar at Crown Metropol |
||||
Day 1 Friday 24th February 2017 |
|||||
|
7:30 |
Registration Opens |
||||
|
8:00 |
Welcome Address ABG 2017 |
||||
|
8:10 |
Prof. Annette Haworth: Australasian Brachytherapy: Where are we going? |
||||
|
8:30 |
Parallel Session (GYN) |
Parallel Session (Physics) |
|||
|
Image guided definitive radiotherapy of cervix cancer |
Physics Research and Development Session Proffered Papers Towards augmented reality: Intraoperative prostate modelling for biopsy and brachytherapy, Mohammad Ali Jan Ghasab, Monash University BrachView: initial preclinical results for a real-time in-body HDR PBT source tracking system with simultaneous TRUS image fusion, Saree Alnaghy, Centre for Medical Radiation Physics, University of Wollongong Characterisation of the Variseed dynamic volume calculation algorithm for Low Dose Rate prostate brachytherapy, Prabha Jones, Alfred Health – Gippsland Radiation Oncology MaxiCalc: a real-time dose calculation engine for use in a HDR brachytherapy source tracking system, Max Hanlon, RMIT University Feature finding for catheter localization in HDR prostate brachytherapy, Kyle Ewart, School of Applied Sciences, RMIT University Implementation of a real-time prostate HDR brachytherapy system, Ryan Brown,St George Cancer Care Centre Verification of skin doses during interstitial brachytherapy APBI, Dean Cutajar, Centre for Medical Radiation Physics, University of Wollongong |
||||
|
9:10 |
Proffered Papers Clinical outcome of CT guided adaptive HDR brachytherapy combined with IMRT with chemotherapy in patients with locally advanced cervical cancer – the Royal Adelaide Hospital Experience, Kasri Abdul Rahim, Department of Radiation Oncology, Royal Adelaide Hospital 3T MR image-guided uterovaginal HDR brachytherapy modulated radiation therapy for cervix cancer – 6 year follow-up of disease outcomes and toxicity, Mark Stevens, Northern Sydney Cancer Centre, Royal North Shore Hospital |
||||
|
9:40 |
Morning Tea (Exhibition Area) |
||||
| 10:05 |
Keynote speaker – Prof. Mark Rivard: Research advances in brachytherapy physics: A perspective on technological advancements[new radionuclides and novel applicators] |
||||
| 10:35 |
Prof. Alexander Heriot, Colerectal Surgeon, Director Cancer Surgery, PMCC |
||||
|
Parallel Session |
Parallel Session | ||||
|
11:05 |
Proffered Papers Interactive biologically-based inverse planning for focal LDR brachytherapy of prostate cancer, Jie Liu, Monash University HDR brachytherapy in vivo source tracking using a 2D diode array: A Monte Carlo study, Joel Poder, Centre of Medical Radiation Physics, University of Wollongong Accounting for previous radiotherapy treatments using deformable image registration: A case study in prostate brachytherapy, Johnson Yuen, St George Hospital, Cancer Care Centre |
Patient Care Session Urethral Strictures and other Complications from Radiation Therapy From Surviving to Thriving: Talking about Life after Prostate Cancer Dealing with Chronic Illness and Staying Positive day-to-day ADT, Prostate Cancer and the Patient
|
|||
| 11:35
|
Keynote speaker – Prof. Mark Rivard:Advances in brachytherapy dose calculation algorithms: State-of-the-art and developments underway |
||||
| 12:10 | Proffered Papers
In-vivo dosimetry: Mehodology and results for HDR brachytherapy surface mould patients treated at the RAH since 2014, Paul Reich, Royal Adelaide Hospital The introduction and validation of a model based dose calculation algorithm for brachytherapy in an Australian centre, Lynsey Hamlett, Townsville Hospital Cancer Centre Do we need a minimum dwell time restriction in HDR brachytherapy treatments? Eeva Boman, Blood & Cancer Centre, Wellington Hospital
|
|
|
||
|
12:40 |
Lunch (Exhibition Area) |
||||
|
13:40 |
Gynaecological Brachytherapy Guest speaker: Dr Graeme Dickie |
||||
|
14:20 |
Proffered Papers Moulds and cylinders: Clinical and dosimetric analysis of an adjuvant image-guided intra-vaginal brachytherapy (IVBT) programme for endometrial cancer, Florence Ko, Northern Sydney Cancer Centre, Royal North Shore Hospital Intracavitary vaginal brachytherapy using a custom balloon applicator, Dean Paterson, Wellington Blood and Cancer Centre Interstitial HDR brachytherapy for an infant with prostate and bladder rhabdomyosarcoma, Emily Flower, Crown Princess Mary Cancer Centre, University of Sydney Optimisation and dosimetric implication of treatment parameter changes in multi-lumen balloon breast brachytherapy, Claire Dempsey, Department of Radiation Oncology, University of Washington, Seattle WA, USA |
||||
|
15:00 |
Afternoon Tea (Exhibition Area) |
||||
|
15:30 |
Keynote speaker – Assoc. Prof. Gerard Morton:HDR Monotherapy for prostate with extreme hypofractionation – (1 or 2 fractions). |
||||
|
16:15 |
Varian sponsored speaker – Dr Bradley Prestidge: RTOG 0232 – Phase III Study Comparing Combined External Beam Radiation And Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone For Selected Patients With Intermediate Risk Prostatic Carcinoma prostate brachytherapy clinical trial |
||||
|
16:45 |
ABG Annual General Meeting |
||||
|
17:30 |
Day 2 concludes |
||||
|
19:00 |
Conference Dinner Arrival Drinks : Zinc Federation Square |
||||
|
19:30 |
Conference Dinner |
||||
|
23:00 |
Conference Dinner Concludes |
||||
Day 2 Saturday 25th February 2017 |
|||||
|
7:30 |
Physics teaching lecture: Keynote speaker – Prof. Mark Rivard: Brachytherapy dose calculations and source strength determination |
||||
|
7:30 |
Registration Opens |
||||
|
8:00 |
Day 3 Welcome |
||||
|
8:05 |
Endometrial cancer and the PORTEC trials: the role of brachytherapy in outcome and quality of life Keynote speaker: Claire Dempsey, University of Washington, Seattle USA |
||||
|
8:40 |
Proffered Papers Round the bend – an unusual oesophageal brachytherapy case, Judith Martland, Northern Sydney Cancer Centre Endobronchial brachytherapy as a palliative intervention: reviewing 20 years of experience in a Australian Centre, Matthew Knox, St George Hospital Surface mould treatments at RAH, Lyndal Newmarch, Royal Adelaide Hospital Electronic brachytherapy: commissioning and clinical experience of the Esteya system for superficial treatments, Bess Sutherland, Radiation Oncology Centres |
||||
|
9:20 |
Keynote speaker – Assoc. Prof. Gerard Morton:Management of high risk prostate cancer including ASCEND trial |
||||
|
10:00 |
Proffered Papers Clinical demonstration of the value of in vivo Brachytherapy Image-Guided Verification (BIGV) in high dose rate prostate brachytherapy, Hayley Mack, Alfred Health Radiation Oncology Re-implatation of iodine-125 seeds for suboptimal prostate brachytherapy post-implant dosimetry clinical and dosimetric outcomes, Andrej Bece, St George Hospital Improved prostate cancer survival with the addition of high dose-rate brachytherapy to external beam radiation treatment and low toxicity with 12 year follow-up, Jeremy Millar, Alfred Health Radiation Oncology Assessing prostate tumour cell density for focal brachytherapy using multiparametric MRI and machine learning techniques, Yu Sun, University of Melbourne
|
||||
|
10:40 |
Morning Tea (Exhibition Area) |
||||
|
11:00 |
Special Session LDR Prostate: Australasian Experience & Long Term Results:
|
||||
|
12:30 |
Lunch (Exhibition Area) |
||||
|
13:30 |
Keynote speaker – Assoc. Prof. Gerard Morton: Salvage brachytherapy following external beam failures |
||||
|
14:00 |
Dr Bronwyn Matheson: Salvage brachytherapy literature review |
||||
|
14:45 |
Proffered Papers Salvage high dose rate brachytherapy for prostate cancer in South Australia, Hien Le, Royal Adelaide Hospital |
||||
|
15:00 |
Afternoon Tea (Exhibition Area) |
||||
|
15:30 |
Keynote speaker – Assoc. Prof. Gerard Morton: Brachytherapy Education |
||||
|
16:05 |
Comprehensive quality management for clinical brachytherapy Keynote speaker: Prof Mark Rivard |
||||
|
16:45 |
Presentations & Wrap-up |
||||
|
17:00 |
Day 3 concludes |
||||
|
17:00 – 19:00 |
Post Session Drinks Promenade Hotel Tonic Bar |
||||
Poster Presentations:
HDR and LDR brachytherapy at the Royal Adelaide Hospital: A statistical review from 2004 to 2016, Wendy Phillips, Mr. John Lawson, Dr. Paul Reich, Royal Adelaide Hospital
APBI in patient with a defibrillator – a case study, Kristine Schreiber, St George Hospital Cancer Care Centre
Quantitative analysis of the Varian film – based position verification test using the DBSCAN clustering algorithm, Claire Dempsey, Department of Radiation Oncology, University of Washington, Seattle WA, USA
The program is correct as at 8 December but it is subject to change